Prudential Financial Inc Puma Biotechnology, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 100,485 shares of PBYI stock, worth $298,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,485

Previous 17,585 471.42%

Holding current value

$298,440

Previous $57,000 349.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.25 - $4.03 $186,525 - $334,087	82,900 Added 471.42%	100,485 $256,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $6,964 - $13,904	2,385 Added 15.69%	17,585 $57,000
Q1 2024 May 14, 2024	SELL	$4.29 - $7.4 $5,148 - $8,880	-1,200 Reduced 7.32%	15,200 $80,000
Q1 2023 May 12, 2023	BUY	$2.21 - $4.82 $12,818 - $27,956	5,800 Added 54.72%	16,400 $50,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $22,472 - $53,848	10,600 New	10,600 $0
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $306,575 - $616,888	-186,936 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.13 - $3.24 $18,105 - $27,540	8,500 Added 4.76%	186,936 $539,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $516,588 - $1.19 Million	-181,259 Reduced 50.39%	178,436 $543,000
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $166,028 - $235,144	-25,042 Reduced 6.51%	359,695 $2.52 Million
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $1.15 Million - $1.48 Million	127,853 Added 49.77%	384,737 $3.53 Million
Q1 2021 May 12, 2021	SELL	$9.38 - $13.63 $255,483 - $371,240	-27,237 Reduced 9.59%	256,884 $2.5 Million
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $485,472 - $756,912	-62,400 Reduced 18.01%	284,121 $2.92 Million
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $2.32 Million - $2.72 Million	244,240 Added 238.79%	346,521 $3.5 Million
Q2 2020 Aug 12, 2020	BUY	$7.01 - $13.24 $692,377 - $1.31 Million	98,770 Added 2813.16%	102,281 $1.07 Million
Q2 2018 Aug 13, 2018	BUY	$48.3 - $68.25 $966 - $1,365	20 Added 0.57%	3,511 $0
Q1 2018 May 04, 2018	BUY	$59.7 - $99.25 $4,776 - $7,940	80 Added 2.35%	3,491 $0
Q4 2017 Feb 13, 2018	SELL	$93.85 - $132.45 $11,262 - $15,893	-120 Reduced 3.4%	3,411 $337,000
Q3 2017 Nov 02, 2017	BUY	$72.0 - $119.75 $254,232 - $422,837	3,531	3,531 $423,000

Others Institutions Holding PBYI

# of Institutions

100

Shares Held

28.9M

Call Options Held

50.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Puma Biotechnology, Inc. Transaction History